Bli medlem
Bli medlem

Du är här


Valmet: Valmet receives repeat order for two new tissue production lines from Lee & Man Paper Manufacturing in China

Valmet Corporation's press release on March 15, 2016 at 11:00 a.m. EET

Valmet will supply two Advantage DCT tissue production lines and related
automation systems to one of China's leading paper and pulp producers,
Lee&Man Manufacturing Ltd. The new lines will be installed at Lee&Man's mill
in Chongqing and start-up is planned to take place in late 2016.

The order is included in Valmet's first quarter 2016 orders received. The
value of the order is not disclosed.

Continuation of good cooperation

The Valmet's Advantage DCT 200HS tissue lines to be delivered are designed for
production of high quality tissue products. The new tissue lines will fulfill
the high requirements for effective technology and sustainability set by
Lee&Man. Previously the company has ordered three Advantage DCT 200HS tissue
lines of which one started up at the Chongqing mill 2015 and two will start
up this year.

"Our first installation in Chongqing is running very well and we are convinced
that the Advantage DCT technology and the partnership with Valmet will
support our market expansion in China," saysRaymond Lee
, Chairman of the Board, Lee&Man.

"It's an honor that Lee&Man have again decided to extend the cooperation which
already includes three tissue machine deliveries to the Chongqing mill. As
seen from the earlier installations, it is possible to reach significant
drying energy savings and highest paper quality by our innovative combination
of flexible pressing, casted Yankee and steam heated hood. With this
combination we are able to bring concrete benefits to our customers and to
take their performance forward," saysSvenerik Olsson
, Director, Tissue Mills Business Unit, Valmet China.

Valmet's Advantage DCT concept is well established on the market and has
proven to enable cost- and energy-efficient production of high quality tissue

Technical information about the delivery

The new tissue machines will have a width of 5.6 m and a design speed of 2,000
m/min. Each machine will produce 60.000 tons of toilet and facial tissue per
year, using virgin wood pulp and bleached bamboo fiber as raw material.

Valmet's scope of delivery will comprise complete tissue production lines
featuring stock preparation systems and Advantage DCT 200HS tissue machines.
The machines will be equipped with OptiFlo headbox and cast alloy Yankee
cylinders. The machines will also be featured with the well proven Advantage
tissue technology including ViscoNip press, steam heated AirCap hood, WetDust
dust system and a SoftReel P reel. Basic engineering, installation
supervision, training, start-up and commissioning are also included

The delivery will also include Valmet's proven automation package including
Valmet DNA machine and process control system (DCS) as well as Valmet IQ
quality control system (QCS) and Valmet IQ Dilution Profiler. The automation
package provides a single source solution, utilizing only one system to
perform all the essential measurements and controls for tissue production.

Valmet Advantage DCT 200HS tissue machine

About the customer Lee&Man Paper Manufacturing

Established in 1994, Lee&Man Paper Manufacturing Ltd has grown from a small
company into a leading paper and pulp manufacturer. The company's 6,500
employees are located at the company's five production sites in China. The
company had a capacity of 7 million tons of container board, duplex board and
tissue paper as well as 180,000 tons of pulp in 2014.

Corporate Communications

For further information, please contact:

Svenerik Olsson, Director, Tissue mills, China area, Valmet, Tel. +86 139

Krister Harnesk, Sales Manager, Tissue mills, Valmet, Tel. + 46 766 397543

Valmet is the leading global developer and supplier of process technologies,
automation and services for the pulp, paper and energy industries. We aim to
become the global champion in serving our customers.

Valmet's strong technology offering includes pulp mills, tissue, board and
paper production lines, as well as power plants for bioenergy production. Our
advanced services and automation solutions improve the reliability and
performance of our customers' processes and enhance the effective utilization
of raw materials and energy.

Valmet's net sales in 2015 were approximately EUR 2.9 billion. Our 12,000
professionals around the world work close to our customers and are committed
to moving our customers' performance forward - every day. Valmet's head
office is in Espoo, Finland and its shares are listed on the Nasdaq Helsinki.

Read more,

IMAGE: Valmet Advantage DCT 200HS tissue machine


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Valmet via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.